£67 million upgrade underway at GSK's Montrose facility
WEBJan 15, 2024 · GSK is planning to invest £200m in its UK manufacturing operations over the next two years. The pharmaceutical giant is currently in the middle of a multi-year £67m upgrade to its Montrose site, which includes a new facility which is …
New £44m facility at GSK Montrose - gov.scot - The Scottish …
WEBAug 15, 2017 · First Minister Nicola Sturgeon welcomed GSK’s (GlaxoSmithKline) commitment to Montrose as she opened their new £44 million aluminium salts facility. The site produces ingredients for vaccines for illnesses including tetanus, pneumonia and whooping cough.
GlaxoSmithKline opens new $56.6M vaccines plant in Scotland
WEBAug 15, 2017 · GlaxoSmithKline opened its new $56.6 million vaccines plant in Montrose, Scotland, that will manufacture sterile aluminum salts and includes a microbiology lab. But the small addition comes as...
Pharma giant GSK's new £44m facility in Montrose ... - The National
WEBAug 16, 2017 · NICOLA Sturgeon has opened a new £44 million facility for pharma giant GSK (GlaxoSmithKline) in Angus which will produce 400 million vaccines every year. GSK’s aluminium salts unit in Montrose makes ingredients for vaccines for various illnesses, including tetanus, pneumonia and whooping cough.
GSK invests in Montrose - gov.scot - The Scottish Government
WEBOct 22, 2018 · GSK’s £54 million new state-of-the-art production building in Montrose has been opened by First Minister Nicola Sturgeon. Active pharmaceutical ingredients (APIs) for use in GSK’s Ellipta respiratory inhalers will be produced in the building which is the second multi-million investment in the Montrose site over the last two years.
Nicola Sturgeon officially opens GlaxoSmithKline's £44m Montrose …
WEBAug 15, 2017 · GSK has chosen the Montrose site to produce these salts, which will supply its vaccines sites in France, Belgium and Singapore, producing round 400 million vaccinations a year to tackle illnesses such as tetanus, pneumonia and whooping cough.
GSK opens £44M aluminum salts facility in Scotland
WEBAug 17, 2017 · Scottish First Minister Nicola Sturgeon has cut the ribbon on GlaxoSmithKline plc’s newest aluminum salts manufacturing plant, located in Montrose, Scotland. The site will supply the British drugmaker’s vaccine …
Nicola Sturgeon opens new £54m GlaxoSmithKline centre
WEBOct 22, 2018 · Nicola Sturgeon officially opened GlaxoSmithKline's £44m facility on the site last year. A £54 million pharmaceutical production centre has been opened by the First Minister. GlaxoSmithKline (GSK) will use the building in Montrose, Angus, to manufacture ingredients for inhalers.
GSK affirms its long-term commitment to manufacturing in Scotland
WEBBuilt at a cost of £44M, the new facility at GSK’s site at Montrose in north-east Scotland will manufacture sterile aluminium salts which are compounds that boost the human body’s response to vaccines and supply them to GSK’s vaccine factories around the world.
GSK invests in Montrose - Life Sciences Scotland
WEBOct 22, 2018 · GSK’s £54 million new state-of-the-art production building in Montrose has been opened by First Minister Nicola Sturgeon. Active pharmaceutical ingredients (APIs) for use in GSK’s Ellipta respiratory inhalers will be produced in the building and it is the second multi-million investment on the Montrose site over the last two years.
Skip to content